Bombesin enhances TGF-β growth inhibitory effect through apoptosis induction in intestinal epithelial cells

Regulatory Peptides

Volumn 158, Issue 1-3, 2009, Pages 26-31

  Liu, Xianghua ^a   Zhao, Junmei ^b   Li, Fazhi ^b   Guo, Yan shi ^b   Hellmich, Mark R ^b   Townsend Jr , Courtney M ^b   Cao, Yanna ^a   Ko, Tien C ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Cell cycle; Gastrin releasing peptide receptor; p38MAPK

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; BOMBESIN; GASTRIN RELEASING PEPTIDE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE P38; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL CELL CULTURE; APOPTOSIS; ARTICLE; CELL CYCLE; CELL GROWTH; CELL LINE; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; ENZYME ACTIVITY; EPITHELIUM CELL; GROWTH INHIBITION; INTESTINE EPITHELIUM; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; BOMBESIN; CELL CYCLE; CELL LINE; EPITHELIAL CELLS; INTESTINAL MUCOSA; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; TRANSFORMING GROWTH FACTOR BETA;

MAMMALIA; RATTUS;

EID: 70349740790     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2009.07.010     Document Type: Article

References (55)

1. Babyatsky M.W., and Podolsky D.K. Growth and development in the gastrointestinal tract. In: Yamada T., Alpers D.H., Owyang C., and Powell D.W. (Eds). Text book of gastroenterology (1991), JB Lippincott Co., Philadelphia 475-501
2. Ko T.C., Bresnahan W.A., and Thompson E.A. Intestinal cell cycle regulation. In: Meijer L., Guidet S., and Philippe M. (Eds). Progress in cell cycle research (1997), Plenum, New York 43-52
3. Cairnie A.B., Lamerton L.F., and Steel G.G. Cell proliferation studies in the intestinal epithelium of the rat. I. Determination of the kinetic parameters. Exp Cell Res 39 (1965) 528-538
4. Potten C.S., Wilson J.W., and Booth C. Regulation and significance of apoptosis in the stem cells of the gastrointestinal epithelium. Stem Cells 15 (1997) 82-93
5. Hahm K.B., Im Y.H., Parks T.W., Park S.H., Markowitz S., Jung H.Y., Green J., and Kim S.J. Loss of transforming growth factor beta signalling in the intestine contributes to tissue injury in inflammatory bowel disease. Gut 49 (2001) 190-198
6. Heldin C.H., Miyazono K., and ten Dijke P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390 (1997) 465-471
7. Massague J. TGF-beta signal transduction. Annu Rev Biochem 67 (1998) 753-791
8. Massague J., Blain S.W., and Lo R.S. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 103 (2000) 295-309
9. Booth D., Haley J.D., Bruskin A.M., and Potten C.S. Transforming growth factor-B3 protects murine small intestinal crypt stem cells and animal survival after irradiation, possibly by reducing stem-cell cycling. Int J Cancer 86 (2000) 53-59
10. Barnard J.A., Beauchamp R.D., Coffey R.J., and Moses H.L. Regulation of intestinal epithelial cell growth by transforming growth factor type beta. Proc Natl Acad Sci U S A 86 (1989) 1578-1582
11. Ko T.C., Sheng H.M., Reisman D., Thompson E.A., and Beauchamp R.D. Transforming growth factor-beta 1 inhibits cyclin D1 expression in intestinal epithelial cells. Oncogene 10 (1995) 177-184
12. Smith R.D. Evidence for autocrine growth inhibition of rat intestinal epithelial (RIE-1) cells by transforming growth factor type-beta. Biochem Mol Biol Int 35 (1995) 1315-1321
13. Ciacci C., Lind S.E., and Podolsky D.K. Transforming growth factor beta regulation of migration in wounded rat intestinal epithelial monolayers. Gastroenterology 105 (1993) 93-101
14. Wang J.Y., Viar M.J., Li J., Shi H.J., McCormack S.A., and Johnson L.R. Polyamines are necessary for normal expression of the transforming growth factor-beta gene during cell migration. Am J Physiol 272 (1997) G713-G720
15. Kurokowa M., Lynch K., and Podolsky D.K. Effects of growth factors on an intestinal epithelial cell line: transforming growth factor beta inhibits proliferation and stimulates differentiation. Biochem Biophys Res Commun 142 (1987) 775-782
16. Dunker N., Schmitt K., Schuster N., and Krieglstein K. The role of transforming growth factor beta-2, beta-3 in mediating apoptosis in the murine intestinal mucosa. Gastroenterology 122 (2002) 1364-1375
17. Cao Y., Chen L., Zhang W., Liu Y., Papaconstantinou H.T., Bush C.R., Townsend Jr. C.M., Thompson E.A., and Ko T.C. Identification of apoptotic genes mediating TGF-beta/Smad3-induced cell death in intestinal epithelial cells using a genomic approach. Am J Physiol Gastrointest Liver Physiol 292 (2007) G28-G38
18. Matsushita M., Matsuzaki K., Date M., Watanabe T., Shibano K., Nakagawa T., Yanagitani S., Amoh Y., Takemoto H., Ogata N., Yamamoto C., Kubota Y., Seki T., Inokuchi H., Nishizawa M., Takada H., Sawamura T., Okamura A., and Inoue K. Down-regulation of TGF-beta receptors in human colorectal cancer: implications for cancer development. Br J Cancer 80 (1999) 194-205
19. Thiagalingam S., Lengauer C., Leach F.S., Schutte M., Hahn S.A., Overhauser J., Willson J.K., Markowitz S., Hamilton S.R., Kern S.E., Kinzler K.W., and Vogelstein B. Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat Genet 13 (1996) 343-346
20. MacGrogan D., Pegram M., Slamon D., and Bookstein R. Comparative mutational analysis of DPC4 (Smad4) in prostatic and colorectal carcinomas. Oncogene 15 (1997) 1111-1114
21. Erspamer G.F., and Cei J.M. Biogenic amines and active polypeptides in the skin of Leptodactylus vilarsi melin. Biochem Pharmacol 19 (1970) 321-325
22. McDonald T.J., Jornvall H., Nilsson G., Vagne M., Ghatei M., Bloom S.R., and Mutt V. Characterization of a gastrin releasing peptide from porcine non-antral gastric tissue. Biochem Biophys Res Commun 90 (1979) 227-233
23. Patel O., Shulkes A., and Baldwin G.S. Gastrin-releasing peptide and cancer. Biochim Biophys Acta 1766 (2006) 23-41
24. Baroni A., Perfetto B., Canozo N., Braca A., Farina E., Melito A., De Maria S., and Carteni M. Bombesin: a possible role in wound repair. Peptides 29 (2008) 1157-1166
25. Sun Y.G., and Chen Z.F. A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord. Nature 448 (2007) 700-703
26. Carroll R.E., Matkowskyj K., Saunthararajah Y., Sekosan M., Battey J.F., and Benya R.V. Contribution of gastrin-releasing peptide and its receptor to villus development in the murine and human gastrointestinal tract. Mech Dev 113 (2002) 121-130
27. West S.D., and Mercer D.W. Bombesin-induced gastroprotection. Ann Surg 241 (2005) 227-231
28. Assimakopoulos S.F., Scopa C.D., Zervoudakis G., Mylonas P.G., Georgiou C., Nikolopoulou V., and Vagianos C.E. Bombesin and neurotensin reduce endotoxemia, intestinal oxidative stress, and apoptosis in experimental obstructive jaundice. Ann Surg 241 (2005) 159-167
29. Guo Y.S., Chen Z., Wen X.D., Ko T.C., Townsend Jr. C.M., and Hellmich M.R. Synergistic regulation of COX-2 expression by bombesin and transforming growth factor-beta. Dig Dis Sci 53 (2007) 2045-2052
30. Cao Y., Deng C., Townsend Jr. C.M., and Ko T.C. TGF-beta inhibits Akt-induced transformation in intestinal epithelial cells. Surgery 140 (2006) 322-329
31. Song S., Freedman J., Mody M., and Lazarus A.H. p38 MAPK is activated but not necessary in porcine von Willebrand factor-dependent platelet activation. Br J Haematol 107 (1999) 532-538
32. Jin Z.J. Addition in drug combination (author's transl). Zhongguo Yao Li Xue Bao 1 (1980) 70-76
33. Zhang K.Z., Xu J.H., Huang X.W., Wu L.X., Su Y., and Chen Y.Z. Curcumin synergistically augments bcr/abl phosphorothioate antisense oligonucleotides to inhibit growth of chronic myelogenous leukemia cells. Acta Pharmacol Sin 28 (2007) 105-110
34. Ko T.C., Beauchamp R.D., Townsend Jr. C.M., Thompson E.A., and Thompson J.C. Transforming growth factor-beta inhibits rat intestinal cell growth by regulating cell cycle specific gene expression. Am J Surg 167 (1994) 14-19 discussion 9-20
35. Cao Y., Liu X., Zhang W., Deng X., Zhang H., Liu Y., Chen L., Thompson E.A., Townsend Jr. C.M., and Ko T.C. TGF-beta repression of Id2 induces apoptosis in gut epithelial cells. Oncogene 28 (2009) 1089-1098
36. Papaconstatinou H.T., and Ko T.C. Cell cycle and apoptosis regulation in GI cancers. In: Evers B.M. (Ed). Molecular mechanisms on gastrointestinal cancer (1999), R.G. Landes Company, Austin 49-78
37. Javelaud D., and Mauviel A. Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: implications for carcinogenesis. Oncogene 24 (2005) 5742-5750
38. Lutz M., and Knaus P. Integration of the TGF-beta pathway into the cellular signalling network. Cell Signal 14 (2002) 977-988
39. Derynck R., and Zhang Y.E. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425 (2003) 577-584
40. Kinzler K.W., and Vogelstein B. Lessons from hereditary colorectal cancer. Cell 87 (1996) 159-170
41. White R.L. Tumor suppressing pathways. Cell 92 (1998) 591-592
42. Cartwright C.A., Meisler A.I., and Eckhart W. Activation of the pp60c-src protein kinase is an early event in colonic carcinogenesis. Proc Natl Acad Sci U S A 87 (1990) 558-562
43. Preston S.R., Woodhouse L.F., Jones-Blackett S., Miller G.V., and Primrose J.N. High-affinity binding sites for gastrin-releasing peptide on human colorectal cancer tissue but not uninvolved mucosa. Br J Cancer 71 (1995) 1087-1089
44. Radulovic S.S., Milovanovic S.R., Cai R.Z., and Schally A.V. The binding of bombesin and somatostatin and their analogs to human colon cancers. Proc Soc Exp Biol Med 200 (1992) 394-401
45. Carroll R., Matkowskyj K., Chakrabarti S., McDonald T., and Benya R. Aberrant expression of gastrin-releasing peptide and its receptor by well-differentiated colon cancers in humans. Am J Physiol 276 (1999) G655-G665
46. Radulovic S., Miller G., and Schally A.V. Inhibition of growth of HT-29 human colon cancer xenografts in nude mice by treatment with bombesin/gastrin releasing peptide antagonist (RC-3095). Cancer Res 51 (1991) 6006-6009
47. Radulovic S., Schally A.V., Reile H., Halmos G., Szepeshazi K., Groot K., Milovanovic S., Miller G., and Yano T. Inhibitory effects of antagonists of bombesin/gastrin releasing peptide (GRP) and somatostatin analog (RC-160) on growth of HT-29 human colon cancers in nude mice. Acta Oncol 33 (1994) 693-701
48. Narayan S., Guo Y.S., Townsend Jr. C.M., and Singh P. Specific binding and growth effects of bombesin-related peptides on mouse colon cancer cells in vitro. Cancer Res 50 (1990) 6772-6778
49. Casanueva F.F., Perez F.R., Casabiell X., Camina J.P., Cai R.Z., and Schally A.V. Correlation between the effects of bombesin antagonists on cell proliferation and intracellular calcium concentration in Swiss 3T3 and HT-29 cell lines. Proc Natl Acad Sci U S A 93 (1996) 1406-1411
50. Guo Y.S., Hellmich M.R., Wen X.D., and Townsend Jr. C.M. Activator protein-1 transcription factor mediates bombesin-stimulated cyclooxygenase-2 expression in intestinal epithelial cells. J Biol Chem 276 (2001) 22941-22947
51. Blay J., and Brown K.D. Characterization of an epithelioid cell line derived from rat small intestine: demonstration of cytokeratin filaments. Cell Biol Int Rep 8 (1984) 551-560
52. Sheng H., Shao J., and DuBois R.N. Akt/PKB activity is required for Ha-Ras-mediated transformation of intestinal epithelial cells. J Biol Chem 276 (2001) 14498-14504
53. Yu W., Murray N.R., Weems C., Chen L., Guo H., Ethridge R., Ceci J.D., Evers B.M., Thompson E.A., and Fields A.P. Role of cyclooxygenase 2 in protein kinase C beta II-mediated colon carcinogenesis. J Biol Chem 278 (2003) 11167-11174
54. Roman C., Saha D., and Beauchamp R. TGF-beta and colorectal carcinogenesis. Microsc Res Tech 52 (2001) 450-457
55. Akhurst R.J., and Derynck R. TGF-beta signaling in cancer-a double-edged sword. Trends Cell Biol 11 (2001) S44-S51